SPOC Proteomics
- | Biotech or pharma, therapeutic R&D
- | Other R&D services
- | Synthesis, analytic, diagnostic services
- | Diagnostics
SPOC Proteomics has developed a breakthrough 'DNA library to Protein library' technology to democratize proteomics ($75B market), with transformative applications in preclinical drug discovery, plasma proteomics, and multi-disease diagnostics. SPOC produces thousands of folded proteins from DNA in nanoscale wells, captured onto biosensor chips, facilitating testing and kinetic data from 1000s of protein, drug bindings, at a fraction of cost and time.
We produce and ship custom and catalog protein/antibody chips to Biopharma and AI drug design companies, and offer screening services in select cases. The 'gene/DNA library to protein library on biosensor chips' platform is our proprietary IP, with patents issued in US, EU and other regions.
Initial paid-partners include a large biopharma (over $100B), top AI drug design company and a speciality drug discovery company (over $50B) - in contracting.
Address
ScottsdaleAZ
United States
)
){kind=logo}
)
){kind=logo}
){kind=logo}
){kind=logo}
)
){kind=logo}
)
)
){kind=logo}
){kind=logo}
)
)
){kind=logo}
){kind=logo}
){kind=logo}